Ira Rosenshein Md Phd LLC is categorized under Family Practice Doctors in Charleston, SC and active since 2008.
Ira Rosenshein Md Phd LLC was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Ira Rosenshein at the company’s single location by writing to 4 Carriage Lane # 302, Charleston, South Carolina SC 29407 or by phoning (843) 766-0856. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Ira Rosenshein Md Phd LLC |
| Contact Person: | Ira Rosenshein |
| Address: | 4 Carriage Lane # 302, Charleston, South Carolina 29407 |
| Phone Number: | (843) 766-0856 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Ira Rosenshein Md Phd LLC was started in 2008 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Ira Rosenshein for inquiries that concern Ira Rosenshein Md Phd LLC by calling the company number (843) 766-0856, as your correspondence is most welcome. Additionally, the physical location of the single location of Ira Rosenshein Md Phd LLC can be found at the coordinates 32.797498,-79.997154 as well as the street address 4 Carriage Lane # 302 in Charleston, South Carolina 29407.
For its online presence, you may visit Ira Rosenshein Md Phd LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.